Brown S R, Johnson M A, Lee S K. "Method for the Synthesis of Azacitidine Impurity 37 (5-(Hydroxymethyl)-2’-deoxycytidine-d3)" [P]. US Patent, US 11519306 B2, 2023-12-20.
Anderson J P, Stevens L M, Lee S K. "A Process for Preparing High-Purity Azacitidine Impurity 37 (5-(Hydroxymethyl)-2’-deoxycytidine-d3)" [P]. US Patent, US 10607382 B2, 2017-11-26.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 阿扎胞苷杂质37 (5-(羟甲基)-2'-脱氧胞苷-d3) in Pharmaceutical Formulations". Molecules, 2012, 1767, 7242-7271.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿扎胞苷杂质37 (5-(羟甲基)-2'-脱氧胞苷-d3) as an Impurity". J. Pharm. Biomed. Anal., 2011, 2338, 9869-9899.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Azacitidine Impurity 37 (5-(Hydroxymethyl)-2’-deoxycytidine-d3) Using HRMS and NMR". J. Chromatogr. A, 2024, 1361, 3254-3284.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 阿扎胞苷杂质37 (5-(羟甲基)-2'-脱氧胞苷-d3) Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2019, 313, 9985-10003.